STOCK TITAN

RxSight CMO sells 5,100 shares to cover RSU taxes

RxSight’s chief medical officer reported RSU vesting, a related tax withholding sale, and substantial indirect holdings via Cricklewood LP.

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

RxSight, Inc. (RXST) reported that Chief Medical Officer Ronald M. Kurtz, MD had 13,425 Restricted Stock Units vest on August 31, 2026, converting into 13,425 shares of common stock. On the same date, he continued to hold 67,120 RSUs directly. On September 2, 2026, 5,100 common shares were sold at $6.96 per share to satisfy tax withholding obligations related to this RSU vesting, which the company notes did not represent a discretionary sale. Separately, 764,610 common shares are held indirectly through Cricklewood LP, an entity over which Dr. Kurtz shares voting and investment control with his spouse.

Positive

  • None.

Negative

  • None.
Insider Kurtz Ronald M MD
Role Chief Medical Officer
Sold 5,100 shs ($35K)
Approx. gross sale proceeds $35K
Type Security Shares Price Value
Sale Common Stock F2 5,100 $6.96 $35K
Exercise Restricted Stock Unit F1, F4 13,425 $0.00 $0.00
Exercise Common Stock F1 13,425 -- --
holding Common Stock F3 -- -- --
Holdings After Transaction: Restricted Stock Unit — 67,120 contracts (Direct); Common Stock — 71,775 shares (Direct); Common Stock — 764,610 shares (Indirect, See footnote)
Footnotes (4)
  1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  2. F2. Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
  3. F3. Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
  4. F4. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029.
Shares sold to cover taxes 5,100 shares Common stock sale on September 2, 2026 to satisfy tax withholding on RSU vesting
Sale price per share $6.96 per share Price for 5,100 common shares sold on September 2, 2026
RSUs vested and converted 13,425 units/shares Restricted Stock Units that vested and converted into common stock on August 31, 2026
RSUs held after transaction 67,120 units Restricted Stock Units directly held by the reporting person after August 31, 2026
Indirectly held common shares 764,610 shares Common stock held indirectly through Cricklewood LP as of August 31, 2026
Restricted Stock Unit financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax withholding obligations financial
"Represents the number of shares sold to cover the tax withholding obligations"
Service Provider financial
"Subject to the Reporting Person continuing to be a Service Provider"
Trading Day financial
"shall vest on the first Trading Day on or after each of August 31, 2026"
A trading day is a calendar day when a stock exchange is open and securities can be bought or sold during its set market hours, like a store’s regular business hours. It matters to investors because price changes, order execution, daily volume, and settlement timing are tied to trading days, so performance, deadlines for trades or option expirations, and short-term strategies are measured and planned around them.
Equity Incentive Plan financial
"as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

FAQ

What insider transactions did RxSight (RXST) report for Ronald M. Kurtz, MD?

The filing reports vesting of 13,425 RSUs into 13,425 common shares on August 31, 2026, and a sale of 5,100 shares on September 2, 2026 to cover tax withholding obligations related to that vesting.

At what price were RxSight (RXST) shares sold in this Form 4?

On September 2, 2026, 5,100 shares of RxSight common stock were sold at $6.96 per share, specifically to satisfy tax withholding obligations associated with RSU vesting.

How many Restricted Stock Units does the RxSight (RXST) CMO still hold after these transactions?

After the August 31, 2026 vesting and conversion, Ronald M. Kurtz, MD is reported to hold 67,120 Restricted Stock Units directly, each representing a contingent right to receive one share of RxSight common stock.

What indirect ownership of RxSight (RXST) shares is disclosed in this Form 4?

The Form 4 discloses that 764,610 common shares are held indirectly through Cricklewood LP. Dr. Kurtz is manager of the general partner and shares voting and investment control of that general partner with his spouse.

Was the RxSight (RXST) insider sale made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as a plan transaction, and the footnotes describe the 5,100-share sale as being solely to cover tax withholding on RSU vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kurtz Ronald M MD

(Last)(First)(Middle)
C/O RXSIGHT, INC.
100 COLUMBIA

(Street)
ALISO VIEJO CALIFORNIA 92656

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Medical Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/31/2026M13,425A(1)76,875D
Common Stock09/02/2026S(2)5,100D$6.9671,775D
Common Stock764,610ISee footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)08/31/2026M13,425 (4) (4)Common Stock13,425$067,120D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
2. Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
3. Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
4. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029.
/s/ Jim Schindler, as Attorney-in-Fact09/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)